The Effects of PP2A on TNF Signaling and Smoke-Induced Lung Injury

PP2A 对 TNF 信号传导和烟雾引起的肺损伤的影响

基本信息

  • 批准号:
    7985794
  • 负责人:
  • 金额:
    $ 44.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-01 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): To date, there are no effective therapies that can counteract the damaging effects of cigarette smoke exposure in the lung. In fact, the age-adjusted mortality for chronic obstructive pulmonary disease (COPD) has risen 71% over the past thirty years. To improve this trend more effective strategies of treating the underlying disease mechanisms need to be developed. We have recently published that superoxide dismutase-1 (SOD1), a lung antioxidant, prevents cigarette smoke-induced inflammation and emphysema formation in mice. Further studies in our laboratory demonstrate that the transgenic expression of human SOD1 and glutathione peroxidase-1 (GPX1) decreases JNK activation and AP-1 signaling within the lungs of mice. Importantly, these events correlate with the antioxidant-mediated increase in protein phosphatase 2A (PP2A) activity. This is significant since PP2A is the primary serine threonine protein phosphatase present in all eukaryotic cells. It dephosphorylates and inactivates both JNK and IKK; thus, PP2A is a major regulator of TNF signaling in the lung. PP2A is a heterotrimer enzyme composed of distinct isoforms of a structural subunit (A), a regulatory subunit (B) and a catalytic subunit (C). Post-translational modifications of the C subunit and dynamic exchange of variable B subunits regulate PP2A substrate specificity, activity, and intracellular distribution. PP2A activity is decreased by tyrosine phosphorylation of Tyr307 and disulfide cross-linking of the catalytic (C) subunit of the enzyme which are processes that are affected by reactive oxygen species(4, 5). SOD1 and GPX1 markedly increased protein phosphatase 2A (PP2A) activity in the lungs of these mice without altering PP2A expression or protein levels. Based on these findings, we hypothesize that redox balance can alter TNF signaling and smoke-induced lung injury by modifying PP2A activity in the lung. Reversible phosphorylation of proteins is the most important reaction for regulating protein function in eukaryotic cells. The intracellular phosphorylation of proteins enables the cell to respond to environmental and nutritional stresses by regulating gene expression, cellular proliferation and cell differentiation. The cell contains a tightly coordinated network of kinases and phosphatases that switch proteins from the phosphorylated to the dephosphorylated state in order to cope with various physiological challenges. While a significant body of research has elucidated the role that protein kinases exert in this process, much less is known about the effects of protein phosphatases. As noted above, PP2A is the major serine-threonine protein phosphatase in all eukaryotic cells. In fact, it accounts for as much as 1% of total cellular protein and for a large fraction of overall cellular phosphatase activity. However, its effects on inflammatory lung diseases such as COPD have not been well studied. This proposal will advance public health by specifically determining how PP2A regulates the TNF signaling pathway which plays a pivotal role in the development of smoke-induced lung injury. This project will achieve these goals by addressing three fundamental questions: 1) Does redox balance affect PP2A activity by modifying the holoenzyme complex? 2) Does modifying PP2A activity alter TNF signaling and affect the development of injurious responses to cigarette smoke exposure in the lung? 3) Does PP2A alter TNF signaling within the lungs of emphysema subjects? It is hoped that the insights gained from these studies will provide a more targeted approach of treating this disease. Importantly, our findings will have important implications for other diseases where TNF signaling and inflammation play a central role. PUBLIC HEALTH RELEVANCE: While a significant body of research has elucidated the role that protein kinases exert in COPD, much less is known about the effects of protein phosphatases. This proposal will advance public health by determining how PP2A, the primary eukaryotic serine/threonine phosphatase, alters the injurious responses to cigarette smoke exposure in the lung.
描述(由申请人提供):迄今为止,没有有效的治疗方法可以抵消香烟烟雾暴露对肺部的损害作用。事实上,慢性阻塞性肺疾病(COPD)的年龄调整死亡率在过去30年中上升了71%。为了改善这一趋势,需要开发更有效的治疗潜在疾病机制的策略。我们最近发表了超氧化物歧化酶-1(SOD 1),一种肺抗氧化剂,可预防香烟烟雾诱导的炎症和肺气肿形成。我们实验室的进一步研究表明,人SOD 1和谷胱甘肽过氧化物酶-1(GPX 1)的转基因表达降低了小鼠肺内JNK活化和AP-1信号传导。重要的是,这些事件与抗氧化剂介导的蛋白磷酸酶2A(PP 2A)活性增加相关。这是重要的,因为PP 2A是存在于所有真核细胞中的主要丝氨酸苏氨酸蛋白磷酸酶。它使JNK和IKK去磷酸化并失活;因此,PP 2A是肺中TNF信号传导的主要调节剂。PP 2A是由结构亚基(A)、调节亚基(B)和催化亚基(C)的不同同种型组成的异源三聚体酶。C亚基的翻译后修饰和可变B亚基的动态交换调节PP 2A底物特异性、活性和细胞内分布。PP 2A活性因Tyr 307的酪氨酸磷酸化和酶催化(C)亚基的二硫键交联而降低,这些过程受活性氧影响(4,5)。SOD 1和GPX 1显著增加了这些小鼠肺中的蛋白磷酸酶2A(PP 2A)活性,而不改变PP 2A表达或蛋白水平。基于这些发现,我们假设氧化还原平衡可以通过改变肺中PP 2A的活性来改变TNF信号传导和烟雾诱导的肺损伤。蛋白质的可逆磷酸化是真核细胞中调节蛋白质功能的最重要的反应。蛋白质的胞内磷酸化使细胞能够通过调节基因表达、细胞增殖和细胞分化来响应环境和营养应激。细胞包含一个紧密协调的激酶和磷酸酶网络,将蛋白质从磷酸化状态转换为去磷酸化状态,以科普各种生理挑战。虽然大量的研究已经阐明了蛋白激酶在这一过程中发挥的作用,但对蛋白磷酸酶的作用知之甚少。如上所述,PP 2A是所有真核细胞中主要的丝氨酸-苏氨酸蛋白磷酸酶。事实上,它占总细胞蛋白质的1%,占总细胞磷酸酶活性的很大一部分。然而,其对炎症性肺病如COPD的影响尚未得到充分研究。该提案将通过具体确定PP 2A如何调节TNF信号通路来促进公共健康,该信号通路在烟雾诱导的肺损伤的发展中起着关键作用。本项目将通过解决三个基本问题来实现这些目标:1)氧化还原平衡是否通过修饰全酶复合物来影响PP 2A活性?2)改变PP 2A活性是否会改变TNF信号传导并影响肺部对香烟烟雾暴露的损伤反应的发展?3)PP 2A是否改变肺气肿受试者肺内的TNF信号传导?希望从这些研究中获得的见解将为治疗这种疾病提供更有针对性的方法。重要的是,我们的发现将对TNF信号和炎症起核心作用的其他疾病产生重要影响。 公共卫生关系:虽然大量研究已经阐明了蛋白激酶在COPD中发挥的作用,但对蛋白磷酸酶的作用知之甚少。该提案将通过确定PP 2A(主要真核丝氨酸/苏氨酸磷酸酶)如何改变肺中对香烟烟雾暴露的有害反应来促进公共卫生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert F Foronjy其他文献

Robert F Foronjy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert F Foronjy', 18)}}的其他基金

The Role of HuR in HIV related COPD
HuR 在 HIV 相关 COPD 中的作用
  • 批准号:
    10548660
  • 财政年份:
    2022
  • 资助金额:
    $ 44.65万
  • 项目类别:
The Role of HuR in HIV related COPD
HuR 在 HIV 相关 COPD 中的作用
  • 批准号:
    10693939
  • 财政年份:
    2022
  • 资助金额:
    $ 44.65万
  • 项目类别:
The Effects of PP2A on TNF Signaling and Smoke-Induced Lung Injury
PP2A 对 TNF 信号传导和烟雾引起的肺损伤的影响
  • 批准号:
    8470691
  • 财政年份:
    2010
  • 资助金额:
    $ 44.65万
  • 项目类别:
The Effects of PP2A on TNF Signaling and Smoke-Induced Lung Injury
PP2A 对 TNF 信号传导和烟雾引起的肺损伤的影响
  • 批准号:
    8277888
  • 财政年份:
    2010
  • 资助金额:
    $ 44.65万
  • 项目类别:
The Effects of PP2A on TNF Signaling and Smoke-Induced Lung Injury
PP2A 对 TNF 信号传导和烟雾引起的肺损伤的影响
  • 批准号:
    8676588
  • 财政年份:
    2010
  • 资助金额:
    $ 44.65万
  • 项目类别:
The Effects of PP2A on TNF Signaling and Smoke-Induced Lung Injury
PP2A 对 TNF 信号传导和烟雾引起的肺损伤的影响
  • 批准号:
    8412115
  • 财政年份:
    2010
  • 资助金额:
    $ 44.65万
  • 项目类别:

相似海外基金

抗酸化能を高めたN-acetylcysteineによる老視と白内障抑制機構の解明
阐明具有增强抗氧化能力的N-乙酰半胱氨酸抑制老花眼和白内障的机制
  • 批准号:
    23K15945
  • 财政年份:
    2023
  • 资助金额:
    $ 44.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10758985
  • 财政年份:
    2023
  • 资助金额:
    $ 44.65万
  • 项目类别:
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10619173
  • 财政年份:
    2022
  • 资助金额:
    $ 44.65万
  • 项目类别:
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
  • 批准号:
    10517287
  • 财政年份:
    2021
  • 资助金额:
    $ 44.65万
  • 项目类别:
A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder
N-乙酰半胱氨酸治疗酒精使用障碍的随机对照试验
  • 批准号:
    nhmrc : 2001375
  • 财政年份:
    2021
  • 资助金额:
    $ 44.65万
  • 项目类别:
    Clinical Trials and Cohort Studies Grants
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
  • 批准号:
    10368472
  • 财政年份:
    2021
  • 资助金额:
    $ 44.65万
  • 项目类别:
N-acetylcysteineの骨治癒促進効果の検討
N-乙酰半胱氨酸促进骨愈合作用的考察
  • 批准号:
    20H01118
  • 财政年份:
    2020
  • 资助金额:
    $ 44.65万
  • 项目类别:
    Grant-in-Aid for Encouragement of Scientists
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10221760
  • 财政年份:
    2020
  • 资助金额:
    $ 44.65万
  • 项目类别:
SLE Treatment with N-acetylcysteine
N-乙酰半胱氨酸治疗 SLE
  • 批准号:
    10188441
  • 财政年份:
    2020
  • 资助金额:
    $ 44.65万
  • 项目类别:
SLE Treatment with N-acetylcysteine
N-乙酰半胱氨酸治疗 SLE
  • 批准号:
    10462621
  • 财政年份:
    2020
  • 资助金额:
    $ 44.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了